semaglutide efficacy

semaglutide efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial 🥼🧪Slide Deck: Efficacy and safety

Name: semaglutide efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial 🥼🧪Slide Deck: Efficacy and safety
Brand: khaima.fr
SKU: 12907894414
Price: 22.32 USD
Availability: InStock
Rating: 4.700200000000001 (20 reviews)

SKU: 12907894414

4.7

EUR22.32 EUR53.32

Pay in 4 interest-free payments of $5.58 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

Early worsening of diabetic retinopathy due to intensive glycaemic control

The most common adverse events with orforglipron were gastrointestinal in nature and included nausea, diarrhea, constipation, vomiting and dyspepsia

(Both medications are also approved to reduce cardiovascular risk in people with known heart disease and either type 2 diabetes or obesity.) Semaglutide belongs to a category of prescription medications known as GLP-1s